Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

(2021) Felix Y. Feng et al.   JAMA Oncology

A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer

(2021) Erik Bovinder Ylitalo et al.   Clinical Epigenetics

Prognostic significance of SDF-1 chemokine and its receptors CXCR4 and CXCR7 involved in EMT of prostate cancer

(2021) Martyna Parol-Kulczyk et al.   CYTOKINE

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C

(2021) Elin Thysell et al.   Molecular Oncology

Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis

(2020) Andreas Schlicker et al.   INTERNATIONAL JOURNAL OF CANCER

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer

(2020) Neil K. Jairath et al.   EUROPEAN UROLOGY

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome

(2019) Peter Hammarsten et al.   MODERN PATHOLOGY

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

(2019) Elin Thysell et al.   Molecular Oncology

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer

(2019) Sami Blom et al.   PROSTATE

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity

(2018) Annika Nordstrand et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response

(2017) Erik Bovinder Ylitalo et al.   EUROPEAN UROLOGY

Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance

(2017) Christine Levesque et al.   Cold Spring Harbor Perspectives in Medicine

Clinical relevance of androgen receptor alterations in prostate cancer

(2017) Emma Jernberg et al.   Endocrine Connections

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence

(2017) Yngve Nordby et al.   Scientific Reports

Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype

(2016) Sofia Halin Bergström et al.   NEOPLASIA

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers

(2014) Christina Hägglöf et al.   PLoS One

The reactive stroma microenvironment and prostate cancer progression

(2012) David A Barron et al.   ENDOCRINE-RELATED CANCER

The Stroma—A Key Regulator in Prostate Function and Malignancy

(2012) Christina Hägglöf et al.   Cancers

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

(2011) Emma Hörnberg et al.   PLoS One

Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients

(2010) S Crnalic et al.   ENDOCRINE-RELATED CANCER

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival

(2010) Christina Hägglöf et al.   PLoS One